Global Sickle Cell Anemia Treatment Market Size, Status and Forecast 2019-2025
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Sickle Cell Anemia Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Blood Transfusion
1.4.3 Pharmacotherapy
1.4.4 Bone Marrow Transplant
1.5 Market by Application
1.5.1 Global Sickle Cell Anemia Treatment Market Share by Application (2014-2025)
1.5.2 Child
1.5.3 Adult
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Sickle Cell Anemia Treatment Market Size
2.2 Sickle Cell Anemia Treatment Growth Trends by Regions
2.2.1 Sickle Cell Anemia Treatment Market Size by Regions (2014-2025)
2.2.2 Sickle Cell Anemia Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Sickle Cell Anemia Treatment Market Size by Manufacturers
3.1.1 Global Sickle Cell Anemia Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Sickle Cell Anemia Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Sickle Cell Anemia Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Sickle Cell Anemia Treatment Key Players Head office and Area Served
3.3 Key Players Sickle Cell Anemia Treatment Product/Solution/Service
3.4 Date of Enter into Sickle Cell Anemia Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Sickle Cell Anemia Treatment Market Size by Type (2014-2019)
4.2 Global Sickle Cell Anemia Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Sickle Cell Anemia Treatment Market Size (2014-2019)
5.2 Sickle Cell Anemia Treatment Key Players in United States
5.3 United States Sickle Cell Anemia Treatment Market Size by Type
5.4 United States Sickle Cell Anemia Treatment Market Size by Application
6 Europe
6.1 Europe Sickle Cell Anemia Treatment Market Size (2014-2019)
6.2 Sickle Cell Anemia Treatment Key Players in Europe
6.3 Europe Sickle Cell Anemia Treatment Market Size by Type
6.4 Europe Sickle Cell Anemia Treatment Market Size by Application
7 China
7.1 China Sickle Cell Anemia Treatment Market Size (2014-2019)
7.2 Sickle Cell Anemia Treatment Key Players in China
7.3 China Sickle Cell Anemia Treatment Market Size by Type
7.4 China Sickle Cell Anemia Treatment Market Size by Application
8 Japan
8.1 Japan Sickle Cell Anemia Treatment Market Size (2014-2019)
8.2 Sickle Cell Anemia Treatment Key Players in Japan
8.3 Japan Sickle Cell Anemia Treatment Market Size by Type
8.4 Japan Sickle Cell Anemia Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Sickle Cell Anemia Treatment Market Size (2014-2019)
9.2 Sickle Cell Anemia Treatment Key Players in Southeast Asia
9.3 Southeast Asia Sickle Cell Anemia Treatment Market Size by Type
9.4 Southeast Asia Sickle Cell Anemia Treatment Market Size by Application
10 India
10.1 India Sickle Cell Anemia Treatment Market Size (2014-2019)
10.2 Sickle Cell Anemia Treatment Key Players in India
10.3 India Sickle Cell Anemia Treatment Market Size by Type
10.4 India Sickle Cell Anemia Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Sickle Cell Anemia Treatment Market Size (2014-2019)
11.2 Sickle Cell Anemia Treatment Key Players in Central & South America
11.3 Central & South America Sickle Cell Anemia Treatment Market Size by Type
11.4 Central & South America Sickle Cell Anemia Treatment Market Size by Application
12 International Players Profiles
12.1 Addmedica
12.1.1 Addmedica Company Details
12.1.2 Company Description and Business Overview
12.1.3 Sickle Cell Anemia Treatment Introduction
12.1.4 Addmedica Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.1.5 Addmedica Recent Development
12.2 Gamida Cell
12.2.1 Gamida Cell Company Details
12.2.2 Company Description and Business Overview
12.2.3 Sickle Cell Anemia Treatment Introduction
12.2.4 Gamida Cell Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.2.5 Gamida Cell Recent Development
12.3 GlycoMimetics
12.3.1 GlycoMimetics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Sickle Cell Anemia Treatment Introduction
12.3.4 GlycoMimetics Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.3.5 GlycoMimetics Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Sickle Cell Anemia Treatment Introduction
12.4.4 Pfizer Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Sickle Cell Anemia Treatment Introduction
12.5.4 Novartis Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Global Blood Therapeutics
12.6.1 Global Blood Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Sickle Cell Anemia Treatment Introduction
12.6.4 Global Blood Therapeutics Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.6.5 Global Blood Therapeutics Recent Development
12.7 Micelle BioPharma
12.7.1 Micelle BioPharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Sickle Cell Anemia Treatment Introduction
12.7.4 Micelle BioPharma Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.7.5 Micelle BioPharma Recent Development
12.8 Bluebird Bio
12.8.1 Bluebird Bio Company Details
12.8.2 Company Description and Business Overview
12.8.3 Sickle Cell Anemia Treatment Introduction
12.8.4 Bluebird Bio Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.8.5 Bluebird Bio Recent Development
12.9 Prolong Pharmaceuticals
12.9.1 Prolong Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Sickle Cell Anemia Treatment Introduction
12.9.4 Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.9.5 Prolong Pharmaceuticals Recent Development
12.10 Modus Therapeutics
12.10.1 Modus Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Sickle Cell Anemia Treatment Introduction
12.10.4 Modus Therapeutics Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.10.5 Modus Therapeutics Recent Development
12.11 Sangamo Biosciences
12.12 Bioverativ
12.13 Imara
12.14 Ironwood Pharmaceuticals
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and FiguresTable Sickle Cell Anemia Treatment Key Market Segments
Table Key Players Sickle Cell Anemia Treatment Covered
Table Global Sickle Cell Anemia Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Sickle Cell Anemia Treatment Market Size Market Share by Type 2014-2025
Figure Blood Transfusion Figures
Table Key Players of Blood Transfusion
Figure Pharmacotherapy Figures
Table Key Players of Pharmacotherapy
Figure Bone Marrow Transplant Figures
Table Key Players of Bone Marrow Transplant
Table Global Sickle Cell Anemia Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Child Case Studies
Figure Adult Case Studies
Figure Sickle Cell Anemia Treatment Report Years Considered
Table Global Sickle Cell Anemia Treatment Market Size 2014-2025 (Million US$)
Figure Global Sickle Cell Anemia Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Sickle Cell Anemia Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Sickle Cell Anemia Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Sickle Cell Anemia Treatment Market Share by Regions 2014-2019
Figure Global Sickle Cell Anemia Treatment Market Share by Regions 2014-2019
Figure Global Sickle Cell Anemia Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Sickle Cell Anemia Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Sickle Cell Anemia Treatment Market Share by Manufacturers (2014-2019)
Figure Global Sickle Cell Anemia Treatment Market Share by Manufacturers in 2018
Table Global Sickle Cell Anemia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Sickle Cell Anemia Treatment Product/Solution/Service
Table Date of Enter into Sickle Cell Anemia Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Sickle Cell Anemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Sickle Cell Anemia Treatment Market Size Share by Type (2014-2019)
Figure Global Sickle Cell Anemia Treatment Market Size Market Share by Type (2014-2019)
Table Global Sickle Cell Anemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Sickle Cell Anemia Treatment Market Size Share by Application (2014-2019)
Figure Global Sickle Cell Anemia Treatment Market Size Market Share by Application (2014-2019)
Figure Global Sickle Cell Anemia Treatment Revenue Market Share by Application in 2018
Figure United States Sickle Cell Anemia Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Sickle Cell Anemia Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Sickle Cell Anemia Treatment Market Share (2018-2019)
Table United States Sickle Cell Anemia Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Sickle Cell Anemia Treatment Market Share by Type (2014-2019)
Table United States Sickle Cell Anemia Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Sickle Cell Anemia Treatment Market Share by Application (2014-2019)
Figure Europe Sickle Cell Anemia Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Sickle Cell Anemia Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Sickle Cell Anemia Treatment Market Share (2018-2019)
Table Europe Sickle Cell Anemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Sickle Cell Anemia Treatment Market Share by Type (2014-2019)
Table Europe Sickle Cell Anemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Sickle Cell Anemia Treatment Market Share by Application (2014-2019)
Figure China Sickle Cell Anemia Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Sickle Cell Anemia Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Sickle Cell Anemia Treatment Market Share (2018-2019)
Table China Sickle Cell Anemia Treatment Market Size by Type (2014-20189) (Million US$)
Table China Sickle Cell Anemia Treatment Market Share by Type (2014-2019)
Table China Sickle Cell Anemia Treatment Market Size by Application (2014-2019) (Million US$)
Table China Sickle Cell Anemia Treatment Market Share by Application (2014-2019)
Figure Japan Sickle Cell Anemia Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Sickle Cell Anemia Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Sickle Cell Anemia Treatment Market Share (2018-2019)
Table Japan Sickle Cell Anemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Sickle Cell Anemia Treatment Market Share by Type (2014-2019)
Table Japan Sickle Cell Anemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Sickle Cell Anemia Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Sickle Cell Anemia Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Sickle Cell Anemia Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Sickle Cell Anemia Treatment Market Share (2018-2019)
Table Southeast Asia Sickle Cell Anemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Sickle Cell Anemia Treatment Market Share by Type (2014-2019)
Table Southeast Asia Sickle Cell Anemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Sickle Cell Anemia Treatment Market Share by Application (2014-2019)
Figure India Sickle Cell Anemia Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Sickle Cell Anemia Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Sickle Cell Anemia Treatment Market Share (2018-2019)
Table India Sickle Cell Anemia Treatment Market Size by Type (2014-2019) (Million US$)
Table India Sickle Cell Anemia Treatment Market Share by Type (2014-2019)
Table India Sickle Cell Anemia Treatment Market Size by Application (2014-2019) (Million US$)
Table India Sickle Cell Anemia Treatment Market Share by Application (2014-2019)
Figure Central & South America Sickle Cell Anemia Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Sickle Cell Anemia Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Sickle Cell Anemia Treatment Market Share (2018-2019)
Table Central & South America Sickle Cell Anemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Sickle Cell Anemia Treatment Market Share by Type (2014-2019)
Table Central & South America Sickle Cell Anemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Sickle Cell Anemia Treatment Market Share by Application (2014-2019)
Table Addmedica Company Details
Table Addmedica Revenue in Sickle Cell Anemia Treatment Business (2014-2019) (Million US$)
Figure Addmedica Revenue Growth Rate in Sickle Cell Anemia Treatment Business (2014-2019)
Table Addmedica Recent Development
Table Gamida Cell Company Details
Table Gamida Cell Revenue in Sickle Cell Anemia Treatment Business (2014-2019)(Million US$)
Figure Gamida Cell Revenue Growth Rate in Sickle Cell Anemia Treatment Business (2014-2019)
Table Gamida Cell Recent Development
Table GlycoMimetics Company Details
Table GlycoMimetics Revenue in Sickle Cell Anemia Treatment Business (2014-2019)(Million US$)
Figure GlycoMimetics Revenue Growth Rate in Sickle Cell Anemia Treatment Business (2014-2019)
Table GlycoMimetics Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Sickle Cell Anemia Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Sickle Cell Anemia Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Sickle Cell Anemia Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Sickle Cell Anemia Treatment Business (2014-2019)
Table Novartis Recent Development
Table Global Blood Therapeutics Company Details
Table Global Blood Therapeutics Revenue in Sickle Cell Anemia Treatment Business (2014-2019)(Million US$)
Figure Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Anemia Treatment Business (2014-2019)
Table Global Blood Therapeutics Recent Development
Table Micelle BioPharma Company Details
Table Micelle BioPharma Revenue in Sickle Cell Anemia Treatment Business (2014-2019)(Million US$)
Figure Micelle BioPharma Revenue Growth Rate in Sickle Cell Anemia Treatment Business (2014-2019)
Table Micelle BioPharma Recent Development
Table Bluebird Bio Company Details
Table Bluebird Bio Revenue in Sickle Cell Anemia Treatment Business (2014-2019)(Million US$)
Figure Bluebird Bio Revenue Growth Rate in Sickle Cell Anemia Treatment Business (2014-2019)
Table Bluebird Bio Recent Development
Table Prolong Pharmaceuticals Company Details
Table Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Treatment Business (2014-2019)(Million US$)
Figure Prolong Pharmaceuticals Revenue Growth Rate in Sickle Cell Anemia Treatment Business (2014-2019)
Table Prolong Pharmaceuticals Recent Development
Table Modus Therapeutics Company Details
Table Modus Therapeutics Revenue in Sickle Cell Anemia Treatment Business (2014-2019)(Million US$)
Figure Modus Therapeutics Revenue Growth Rate in Sickle Cell Anemia Treatment Business (2014-2019)
Table Modus Therapeutics Recent Development
Table Sangamo Biosciences Company Details
Table Bioverativ Company Details
Table Imara Company Details
Table Ironwood Pharmaceuticals Company Details
Table Global Sickle Cell Anemia Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Sickle Cell Anemia Treatment Market Size Share by Regions (2019-2025)
Figure Global Sickle Cell Anemia Treatment Market Size Share by Regions in 2025
Figure United States Sickle Cell Anemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Sickle Cell Anemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Sickle Cell Anemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Sickle Cell Anemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Sickle Cell Anemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Sickle Cell Anemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Sickle Cell Anemia Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Sickle Cell Anemia Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Sickle Cell Anemia Treatment Market Size by Product (2019-2025)
Figure Global Sickle Cell Anemia Treatment Market Size by Product in 2025
Table Global Sickle Cell Anemia Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Sickle Cell Anemia Treatment Market Size by Application (2019-2025)
Figure Global Sickle Cell Anemia Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources